Compared with vehicle and monotherapy treated tumors, tumor tissues isolated from mice treated with combination therapy had reduced proliferation, as indicated by immunostaining of Ki67 in both CDXs and PDXs (Fig. 5E, J). This evidence concerns the gene MKI67 and neoplasm.